This year at Medtec Europe, Lubrizol LifeSciences will highlight new compounding capabilities for Pellethane® TPU and Isoplast® ETPU products. Lubrizol’s new compounding offering includes color matching and custom colors for brand recognition, safe identification, and aesthetics in medical device applications, as well as compounding of radiopacifiers such as barium and tungsten for X-ray identification and proper device positioning. This new offering complements LifeSciences’ portfolio of full service capabilities enabling the simplification of customer’s supply chain and ensuring success in the medical device industry.
“When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process,” states Robert Miller, general manager, Lubrizol LifeSciences. “With a long history of polymer expertise and recent investments, Lubrizol LifeSciences is positioned to offer full-service development for next generation medical and drug-eluting device innovations.”
To show further commitment to the medical and drug-eluting device markets, Lubrizol LifeSciences has invested significantly to expand its global development and manufacturing facilities, positioning Lubrizol to better serve the growing market for medical device development and contract manufacturing. This capital investment will expand multiple facilities and increase Lubrizol LifeSciences’ in-house engineering capacity for both silicone and thermoplastic products. Part of this investment expands Vesta’s thermoplastic capabilities to include tip forming, tube flaring, pad printing, hole punching/drilling, precision cutting, reflow, braided tubing lamination and more.
Vesta offers custom contract manufacturing services, including precision silicone and thermoplastic extrusion as well as comprehensive silicone fabrication. With decades of experience, the company’s service, engineering expertise and commitment to quality are sought by customers worldwide.